相关实验视频
Updated: Jul 8, 2025

Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
疾病负担和预测因素与慢性自发性疹症中不响应抗组胺疗法相关
Weily Soong1, Dhaval Patil2, Irina Pivneva3
1AllerVie Health and AllerVie Clinical Research, 504 Brookwood Blvd, Birmingham, AL, 35209, USA.
许多慢性自发性疹 (CSU) 患者对标准抗组胺药物治疗没有反应,导致医疗保健使用量增加和并发症. 早期疾病控制对于有效管理CSU患者至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 医疗保健服务研究 医疗服务研究
背景情况:
- H1-抗组胺剂 (H1AH) 是慢性自发性疹 (CSU) 的第一线治疗药物.
- 50%的CSU患者经历了标准H1AH剂量不足的疾病控制.
- 失控的CSU显著影响患者的福祉和医疗保健资源利用率 (HRU).
研究的目的:
- 评估CSU患者对H1AH治疗无反应的并发症负担和HRU.
- 确定与对基于H1AH的疗法无反应相关的预测因子.
- 强调需要改进民间社会联盟管理战略的需要.
主要方法:
- 对已删除身份的电子健康记录数据 (2007-2020年) 的回顾性分析.
- 开始H1AH治疗的成年CSU患者根据12个月的治疗模式被分为响应者或不响应者.
- 机器学习确定了非响应的基线预测因素;HRU在治疗开始前和后进行了评估.
主要成果:
- 在17062名CSU患者中,超过86%被归类为对H1AH治疗无反应者.
- 非响应者表现出更高的基线并发病率,多药性和特定实验室测试利用率.
- 与响应者相比,非响应者显示了更多的专家访问和随访期间住院病例的显著增加.
结论:
- 在接受H1AH治疗的CSU患者中,很大一部分患者患有不受控制的疾病,导致HRU和患者负担增加.
- 非响应者出现更大的并发症和HRU,住院病例显著增加,强调早期干预的必要性.
- 优化CSU治疗策略对于缓解疾病进展和减少医疗保健系统压力的必要.
更多相关视频
03:40Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
相关概念视频
Allergic Drug Reactions
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Allergic Reactions
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...